Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114920775B details novel axial chiral bisindole catalyst synthesis offering high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel synthesis method for axial chiral indole pyrrole-furan compounds with high enantioselectivity and yield, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106478720B details a metal-free oxazoline catalyst enabling high-purity pharmaceutical intermediates with reduced environmental impact and scalable production capabilities.
Patent CN118878452B reveals novel antitumor compound synthesis. Offers mild conditions and high yield for pharmaceutical intermediate supply chains. Enables cost reduction in API manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel ruthenium-catalyzed route for E-configuration monofluoro alkenyl silicon. Reduces steps and cost for pharmaceutical intermediates manufacturing.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Enables cost reduction in pharmaceutical manufacturing and high-purity API supply chain reliability.
Novel synthesis method offers high enantioselectivity and mild conditions for pharmaceutical intermediates manufacturing supply chain cost reduction and reliability improvements.
Patent CN114409714B reveals a palladium-catalyzed route for planar chiral ferrocenes. This method offers high enantioselectivity and scalable manufacturing for global supply chains.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for scalable production of bioactive heterocycles.
Novel protonic acid catalysis reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN120172978B details a mild trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and scalable supply chain solutions.
Novel patent CN121378226A reveals mild synthesis for oxindole compounds. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Novel one-pot Suzuki coupling method for Darolutamide intermediate. Eliminates column chromatography, reduces cost, ensures supply continuity for pharmaceutical manufacturing.
Patent CN114805209B details a metal-free photocatalytic route for 3-aryl-2H-indazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113307778A reveals a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate supply.
Patent CN111233852A discloses a benzoisofuran-based ligand for asymmetric fluorination, offering mild conditions and high stereoselectivity for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield indoline pyrrole synthesis. Cost-effective scalable production for pharmaceutical intermediates supply chain.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.